chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash started right side of neck (15Apr)midday, clear up and rash appear left top side on back and lightly in vaccine arm area; Rash start right side of neck (15Apr)midday, clear up and rash appear left top side on my back andlightly in vaccine arm area.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 04Apr2021 at 08:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia and periodontal disease. Concomitant medications included iron (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 12:00, the patient experienced rash started right side of neck, clear up and rash appear left top side on back and lightly in vaccine arm area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rash started right side of neck, clear up and rash appear left top side on back and lightly in vaccine arm area was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: A little while after the shot started getting a sharp pain in right foot, it is very sudden.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient did not receive any other medications within two weeks of vaccination. On 15Apr2021 at 15:45, a little while after the shot, the patient started getting a sharp pain in the right foot, it was very sudden and lasted for a few seconds then gone away for a while. It had occurred every 30 minutes or so since about 2 hours after the shot. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sharp pain in right foot was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever within 24 hours after 2nd dose of vaccine; Chills within 24 hours after 2nd dose of vaccine; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patients' medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date, within 24 hours after the second dose, the patient experienced fever and chills. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the events fever and chills were resolved on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Joint stiffness, Pain, Swelling
Clinical narrative: All joints stiff; Hands feel as though they are swollen; Headache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 11Apr2021 at 19:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfas allergy) and protein allergy (whey Proteins). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 at 00:00, the patient experienced all joints stiff, hands felt as though they were swollen, head and body ache x2days. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events headache and body ache were recovered on 14Apr2021. The clinical outcome of the events all joints stiff, hand felt swollen were recovering at the time of this report.  No follow up attempts needed; information about lot number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: Nodules in arm pit of left arm; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient allergies to medications, food, or other products were reported as none known. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021, the patient experienced nodules in arm pit of left arm. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event nodules in arm pit of left arm was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Pregnancy test, Vaginal discharge
Clinical narrative: Missed period; abnormally high amounts of clear, non-stretchydischarge; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZR8730) via an unspecified route of administration on 26Mar2021 at 18:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient had missed period with abnormally high amounts of clear, non-stretchy discharge. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent for pregnancy test on an unknown date and the results were found to be negative. The clinical outcome of the events missed period with abnormally high amounts of clear, non-stretchy discharge were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Migraine
Clinical narrative: Migraine; Anxiety; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 15:00, the patient experienced migraine and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events migraine and anxiety was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate abnormal, Hypoaesthesia, Peripheral swelling, Swelling face
Clinical narrative: Numbness of right arm down to the fingers; Slight swelling of the right arm down to the fingers; Facial swelling around the mouth and cheeks; Accelerated heart rate; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 14:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient previously took ciprofloxacin and experienced drug allergy. The patient was allergic to sulfa drugs and ciprofloxacin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 09Apr2021 at 15:00, the patient experienced numbness and slight swelling of the right arm down to the fingers within first 30 minutes and continued for several hours then reduced to light swelling without numbness into the next day and then "tapered off". On 09Apr2021 first night of vaccine, patient noticed that facial swelling around the mouth and cheeks with slight numbness which disappeared during the day then returned again next night with less noticeable swelling around the mouth. On 09Apr2021 and 10Apr2021, during the first and second night of vaccine patient noticed an accelerated heart rate which kept patient up for a few hours but patient felt asleep and awoke fine. Patient was told that she was breathing "funny" like a dog on the first night of vaccine which prompted her fiance to woke up and make sure she was fine.  Patient felt fine when she was awakened. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events numbness and slight swelling of the right arm down to the fingers was recovered on 10Apr2021 after the duration of 1 day. The outcome of the event accelerated heart rate was recovered on 11Apr2021 after the duration of 2 days. while the event of facial swelling around the mouth and cheeks was recovered on unspecified date Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Tremor
Clinical narrative: Nerve pain; internal tremors; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EL9264) via an unspecified route of administration in the left arm on 01Apr2021 at 15:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient had known allergies to gluten, dairy and shellfish. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Apr2021, at 12:00 hours, the patient experienced nerve pain. On an unknown date in Apr2021, the patient experienced internal tremors. Therapeutic measures were not taken as a result of the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event internal tremors was unknown at the time of report. The clinical outcome of the event nerve pain was recovered on 03Apr2021, after the duration of 12 hours.   No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: Intense chills; aches; headache; general fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 22-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 (at the age of 22-year-old)as a single dose for COVID-19 immunisation. Medical history were reported as none. The patient did not receive any other medications within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced intense chills, aches, headache and general fatigue. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events intense chills, aches, headache and general fatigue was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle tightness, Pain, Vaccination site pain
Clinical narrative: Injection site soreness and tense area; Injection site soreness and tense area; Cannot lift the arm up from tightness and slight pain; Pain only when attempting to lift arm; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 15Apr2021 at 13:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included hydrochlorothiazide, losartan (HYDROCHLOROTHIAZIDE; LOSARTAN) for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 21:00, the patient experienced injection site soreness and tense area, could not lift the arm up from tightness and slight pain and experienced pain only when attempting to lift arm. The patient felt as if got hit in the area and had resulted in soreness. The patient was keeping arm down, but rotating hand rotor cuff resulted in muscle movement at the injection site (upper arm) and caused slight pain at site. Thus, patient needed to keep arm down and tucked to body. The patient had no other effects at the time of reporting. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event injection site soreness and tense area, cannot lift the arm up from tightness and slight pain and pain only when attempting to lift arm was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Chills; Fever; Muscle aches; This is a spontaneous report from a non-contactable nurse, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included history of cancer, no chronic conditions and COVID-19. The patient did not have any allergies to medication, food or other products. Concomitant medications included curcuma longa rhizome (TURMERIC) and multivitamin (Unspecified); from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 (also reported start time as 23:30), 10 hours after vaccine, the patient experienced chills, fever and muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills, fever and muscle aches were resolved on 11Apr2021 (lasting 2 days).  No follow-up attempts are possible. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: feeling dizzy; Nauseous; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6198) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19.  On 10Apr2021 at 10:00 the patient experienced feeling dizzy, nauseous and vomiting. The patient had reported of feeling dizzy and nauseous before vomiting. The patient appeared to feel recovered approximately 12 hours later. No therapeutic measures were taken as a result of the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of feeling dizzy, nauseous and vomiting was recovered on 10Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Slight fever; Chills; Headache; Fatigue; Pain in left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 11Apr2021 at 10:45(at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to food, medications or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on 22Mar2021 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 15:30 the patient experienced slight fever, chills, headache, fatigue and pain in left arm. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, slight fever, chills, headache, fatigue and pain in left arm was recovered on unknown date on Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Dizziness, Feeling cold, Testicular pain
Clinical narrative: Burning sensation covering entire body; Sudden flashes of intense cold; Dizziness; Dull ache in the balls; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 03:00, the patient experienced a burning sensation covering the entire body with sudden flashes of intense cold alongside dizziness that persisted even when lain down, topped off with a dull ache in the balls. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning sensation covering entire body, sudden flashes of intense cold, dizziness, and dull ache in the balls were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: Chills; Fatigue; Full body ache; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 17:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. It was unknown whether the patient was pregnant at the time of vaccination. The patient did not have any allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Apr2021 at 09:00 the patient experienced chills, fatigue and full body ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events chills, fatigue and full body ache were not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Musculoskeletal stiffness, Pyrexia
Clinical narrative: Fever of 100.6 for 12 hours. Now fever has been at 99 for another 12 hours; Arm was immovable; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 14Apr2021 at 10:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications in two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date in 2021 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 18:00, the patient experienced fever of 100.6 for 12 hours, now fever has been at 99 for another 12 hours and arm was immovable until 11:00 this morning since yesterday the day of vaccine at 6. The patient had no reaction to the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 15Apr2021 at 18:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100.6 (units unspecified). On 16Apr2021, the patient underwent lab test and procedure which included body temperature and result was shown as 99 (units unspecified). The clinical outcome of the events fever of 100.6 for 12 hours, now fever has been at 99 for another 12 hours was resolving and the clinical outcome of arm was immovable was resolved on 16Apr2021 at 11:00.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 13Apr2021 at 11:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included mild TBI (traumatic brain injury), aneurysm, craniotomy (for aneurysm) and brain swelling in 2014. Concomitant medications included levetiracetam (KEPPRA), cetirizine hydrochloride (ZYRTEC), montelukast sodium (SINGULAIR), norethisterone (NORETHINDRONE) and hydrochlorothiazide (HYDROCHLOROTH), all started from an unspecified date and for an unknown indication, and taken within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient previously received doxycycline (MANUFACTURER UNKNOWN) and  sulfamethoxazole; trimethoprim(BACTRIM) on unknown dates and for unknown indications which caused drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 12:00, the patient developed a rash at the injection site. The rash had progressively gotten larger over the past few days since receiving the shot. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the event rash at the injection site was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Oral herpes, Viral pharyngitis
Clinical narrative: Presumably viral, pharyngitis; Oral mucosal cold sores; This is a spontaneous report from a contactable pharmacist.  A 45-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via intramuscular route of administration in the right arm on 23Mar2021 at 17:30(at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food or other products. Patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient experienced presumably viral pharyngitis and oral mucosal cold sores. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event presumably viral pharyngitis and oral mucosal cold sores was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature increased, Chest pain, Chills, Nausea
Clinical narrative: chills; nausea; an elevated temp not rising above 100degF; sharp pain in  chest/abdomen on the left side; sharp pain in  chest/abdomen on the left side; It was made much worse when taking a deep breath or a deep exhalation/ The next day the pain had worsened and lying down in any position was debilitatingly painful with any breathing.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 15:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver (Recent diagnosis of slight Fatty Liver in the past 6 weeks). Patient had no known allergies. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) 200 mg one daily, and fluoxetine (MANUFACTURER UNKNOWN) 20 mg one daily, both from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 08:00, the patient experienced awoke to a sharp pain in chest/abdomen on the left side. The pain was such that he could not lay on that side. It was made much worse when taking a deep breath or a deep exhalation. On 15Apr2021, the patient experienced the pain had worsened and lying down in any position was debilitatingly painful with any breathing. Concurrently he experienced chills, nausea, and an elevated temp not rising above 100 degF. Patient reported that his GP and GI doctor referred him to the ER where a chest x-ray, EKG, and bloodwork was taken. No anomalies were found; spleen was not enlarged. Both the GI doctor prior and separately the ER doctor speculated it may be related to the vaccine (potentially causing inflammation) given the timeframe of onset. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events awoke to a sharp pain in chest/abdomen on the left side, the pain was such that he could not lay on that side. It was made much worse when taking a deep breath or a deep exhalation, pain had worsened and lying down in any position was debilitatingly painful with any breathing, experienced chills, nausea, and an elevated temp not rising above 100 degF was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Painful respiration
Clinical narrative: chills; nausea; an elevated temp not rising above 100degF; sharp pain in  chest/abdomen on the left side; sharp pain in  chest/abdomen on the left side; It was made much worse when taking a deep breath or a deep exhalation/ The next day the pain had worsened and lying down in any position was debilitatingly painful with any breathing.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 15:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver (Recent diagnosis of slight Fatty Liver in the past 6 weeks). Patient had no known allergies. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) 200 mg one daily, and fluoxetine (MANUFACTURER UNKNOWN) 20 mg one daily, both from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 08:00, the patient experienced awoke to a sharp pain in chest/abdomen on the left side. The pain was such that he could not lay on that side. It was made much worse when taking a deep breath or a deep exhalation. On 15Apr2021, the patient experienced the pain had worsened and lying down in any position was debilitatingly painful with any breathing. Concurrently he experienced chills, nausea, and an elevated temp not rising above 100 degF. Patient reported that his GP and GI doctor referred him to the ER where a chest x-ray, EKG, and bloodwork was taken. No anomalies were found; spleen was not enlarged. Both the GI doctor prior and separately the ER doctor speculated it may be related to the vaccine (potentially causing inflammation) given the timeframe of onset. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events awoke to a sharp pain in chest/abdomen on the left side, the pain was such that he could not lay on that side. It was made much worse when taking a deep breath or a deep exhalation, pain had worsened and lying down in any position was debilitatingly painful with any breathing, experienced chills, nausea, and an elevated temp not rising above 100 degF was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia, Tinnitus
Clinical narrative: The tinnitus on my right ear is louder than usual, and the noise type now has frequent variations--noticed this change after the other symptoms went away; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 03Apr2021 at 16:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included rosacea, tinnitus, acne cystic, marginal eye ulcers. The patient previously had peanut and experienced mild peanut allergy. Concomitant medications taken within two weeks of vaccination included tretinoin (MANUFACTURER UNKNOWN), metronidazole (MANUFACTURER UNKNOWN), simeticone (GAS-X) and cetirizine hydrochloride (ZYRTEC), antiacids; all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had arm pain, low grade fever, tiredness, and a headache on 04Apr2021 and 05Apr2021. On 06Apr2021 the patients tinnitus on her right ear was louder than usual, and the noise type had frequent variations-- she noticed this change after the other symptoms went away. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events arm pain, low grade fever, tiredness, and a headache on 04Apr2021 and 05Apr2021 was resolved on 05Apr2021. The clinical outcome of the event tinnitus on right ear was louder than usual, and the noise type had frequent variations-- noticed this change after the other symptoms went away was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Flushing, Hot flush, Lip swelling, Swelling face
Clinical narrative: Lower half of face swelled; Lips swollen; Tongue swollen; Face and lips flushed bright red; Voice became hoarse; Hot flashes through chest and arms; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 30Mar2021 at 18:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune allergic condition (autoimmune disorder), allergy to sulfa drugs and allergy to shellfish since unknown dates. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and lovastatin (MANUFACTURER UNKNOWN); all for an unknown indications and from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 18:45, the patient experienced lower half of face swelled, lips and tongue swollen, face and lips flushed bright red, voice became hoarse, hot flashes through chest and arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lower half of face swelled, lips swollen, tongue swollen, face and lips flushed bright red, voice became hoarse and hot flashes through chest and arms were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: Lower half of face swelled; Lips swollen; Tongue swollen; Face and lips flushed bright red; Voice became hoarse; Hot flashes through chest and arms; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 30Mar2021 at 18:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune allergic condition (autoimmune disorder), allergy to sulfa drugs and allergy to shellfish since unknown dates. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and lovastatin (MANUFACTURER UNKNOWN); all for an unknown indications and from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 18:45, the patient experienced lower half of face swelled, lips and tongue swollen, face and lips flushed bright red, voice became hoarse, hot flashes through chest and arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lower half of face swelled, lips swollen, tongue swollen, face and lips flushed bright red, voice became hoarse and hot flashes through chest and arms were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Fatigue, Headache, Nausea
Clinical narrative: Headache; Nausea; Fatigue; Vomiting; Stomach Pains; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to ampicillin (MANUFACTURER UNKNOWN) and Augmentin antibiotics. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 04:00 the patient experienced headache, nausea, fatigue, vomiting, stomach pains and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events headache, nausea, fatigue, vomiting, stomach pains and chills were recovered on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; Nausea; Fatigue; Vomiting; Stomach Pains; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to ampicillin (MANUFACTURER UNKNOWN) and Augmentin antibiotics. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 04:00 the patient experienced headache, nausea, fatigue, vomiting, stomach pains and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events headache, nausea, fatigue, vomiting, stomach pains and chills were recovered on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.